Localization of unlabeled bepirovirsen antisense oligonucleotide in murine tissues using in situ hybridization and CARS imaging

• Published in: RNA (Cambridge) Vol. 29; no. 10; pp. 1575 - 1590
• Main Authors: Spencer-Dene, Bradley, Mukherjee, Prabuddha, Alex, Aneesh, Bera, Kajari, Tseng, Wei-Ju, Shi, Jindou, Chaney, Eric J, Spillman, Jr, Darold R, Marjanovic, Marina, Miranda, Elena, Boppart, Stephen A, Hood, Steve R
• Format: Journal Article
• Language: English
• Published: United States Cold Spring Harbor Laboratory Press 01.10.2023
• Subjects: Animals; Antisense oligonucleotides; Antisense therapy; Cell lineage; Hepatocytes; Humans; Hybridization; Image processing; Immunohistochemistry; In Situ Hybridization; Kidneys; Liver; Liver - diagnostic imaging; Liver - metabolism; Localization; Mice; Oligonucleotides, Antisense - genetics; Oligonucleotides, Antisense - metabolism; Paraffin; Proximal tubules; Renal tubules; Staining and Labeling; Tissue Distribution; label-free imaging; miRNAscope; multiphoton imaging; coherent anti-Stokes Raman scattering; antisense oligonucleotides; pharmacokinetics; in situ hybridization
• ISSN: 1355-8382; 1469-9001
• DOI: 10.1261/rna.079699.123

Current methods for detecting unlabeled antisense oligonucleotide (ASO) drugs rely on immunohistochemistry (IHC) and/or conjugated molecules, which lack sufficient sensitivity, specificity, and resolution to fully investigate their biodistribution. Our aim was to demonstrate the qualitative and quantitative distribution of unlabeled bepirovirsen, a clinical stage ASO, in livers and kidneys of dosed mice using novel staining and imaging technologies at subcellular resolution. ASOs were detected in formalin-fixed paraffin-embedded (FFPE) and frozen tissues using an automated chromogenic in situ hybridization (ISH) assay: miRNAscope. This was then combined with immunohistochemical detection of cell lineage markers. ASO distribution in hepatocytes versus nonparenchymal cell lineages was quantified using HALO AI image analysis. To complement this, hyperspectral coherent anti-Stokes Raman scattering (HS-CARS) imaging microscopy was used to specifically detect the unique cellular Raman spectral signatures following ASO treatment. Bepirovirsen was localized primarily in nonparenchymal liver cells and proximal renal tubules. Codetection of ASO with distinct cell lineage markers of liver and kidney populations aided target cell identity facilitating quantification. Positive liver signal was quantified using HALO AI, with 12.9% of the ASO localized to the hepatocytes and 87.1% in nonparenchymal cells. HS-CARS imaging specifically detected ASO fingerprints based on the unique vibrational signatures following unlabeled ASO treatment in a totally nonperturbative manner at subcellular resolution. Together, these novel detection and imaging modalities represent a significant increase in our ability to detect unlabeled ASOs in tissues, demonstrating improved levels of specificity and resolution. These methods help us understand their underlying mechanisms of action and ultimately improve the therapeutic potential of these important drugs for treating globally significant human diseases.